Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

Clinical trial NCT07580638 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07580638
Sponsor: Chipscreen Biosciences, Ltd.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2026-07-18
Primary completion: 2028-01-18
Enrollment: 3550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.